{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:10:21Z","timestamp":1790514621622,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12916-017-0804-x","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T18:08:12Z","timestamp":1486663692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["When is proton pump inhibitor use appropriate?"],"prefix":"10.1186","volume":"15","author":[{"given":"Rena","family":"Yadlapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kahrilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"804_CR1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2008.12.015","volume":"136","author":"JE Everhart","year":"2009","unstructured":"Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009;136:376\u201386.","journal-title":"Gastroenterology"},{"key":"804_CR2","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2010.91","volume":"105","author":"CW Howden","year":"2010","unstructured":"Howden CW, Kahrilas PJ. Editorial: just how \"difficult\" is it to withdraw PPI treatment? Am J Gastroenterol. 2010;105:1538\u201340.","journal-title":"Am J Gastroenterol"},{"key":"804_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","volume":"14","author":"C Scarpignato","year":"2016","unstructured":"Scarpignato C, Gatta L, Zullo A, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179.","journal-title":"BMC Med"},{"key":"804_CR4","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2006.00844.x","volume":"101","author":"MA Qadeer","year":"2006","unstructured":"Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101:2646\u201354.","journal-title":"Am J Gastroenterol"},{"key":"804_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11894-013-0318-4","volume":"15","author":"RD Naik","year":"2013","unstructured":"Naik RD, Vaezi MF. Extra-esophageal manifestations of GERD: who responds to GERD therapy? Curr Gastroenterol Rep. 2013;15:318.","journal-title":"Curr Gastroenterol Rep"},{"key":"804_CR6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/j.ajkd.2015.05.012","volume":"66","author":"BC Kieboom","year":"2015","unstructured":"Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, et al. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015;66:775\u201382.","journal-title":"Am J Kidney Dis"},{"key":"804_CR7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238\u201346.","journal-title":"JAMA Intern Med"},{"key":"804_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2036.2006.03127.x","volume":"24","author":"M Jalving","year":"2006","unstructured":"Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24:1341\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"804_CR9","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310:2435\u201342.","journal-title":"JAMA"},{"key":"804_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:483\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"804_CR11","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.4238\/2015.July.3.25","volume":"14","author":"HB Xu","year":"2015","unstructured":"Xu HB, Wang HD, Li CH, et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis. Genet Mol Res. 2015;14:7490\u2013501.","journal-title":"Genet Mol Res"},{"key":"804_CR12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","volume":"152","author":"CF Tsai","year":"2017","unstructured":"Tsai CF, Chen MH, Wang YP, et al. Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study. Gastroenterology. 2017;152:134\u201341.","journal-title":"Gastroenterology"},{"key":"804_CR13","doi-asserted-by":"publisher","unstructured":"Lam JR, Schneider JL, Quesenberry CP, et al. Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology. 2016. doi: 10.1053\/j.gastro.2016.11.023 . Ahead of print.","DOI":"10.1053\/j.gastro.2016.11.023"},{"key":"804_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2016.44","volume":"13","author":"L Kia","year":"2016","unstructured":"Kia L, Kahrilas PJ. Therapy: risks associated with chronic PPI use - signal or noise? Nat Rev Gastroenterol Hepatol. 2016;13:253\u20134.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:12:12Z","timestamp":1498385532000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0804-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]},"article-number":"36"}}